Back to Researchresearch

Microglia-mediated synaptic pruning in neural circuit remodeling: multidimensional control in homeostasis and neuropathology

Microglia, the resident immune cells of the central nervous system, are key regulators of synaptic plasticity and neural circuit homeostasis. This review summarizes the mechanisms by which microglia shape synaptic structure and function, including dy...

Body Mind StateJuly 9, 20261 min read
Microglia-mediated synaptic pruning in neural circuit remodeling: multidimensional control in homeostasis and neuropathology

Key Findings

Microglia, the resident immune cells of the central nervous system, are key regulators of synaptic plasticity and neural circuit homeostasis. This review summarizes the mechanisms by which microglia shape synaptic structure and function, including dynamic synaptic interactions, selective pruning, epigenetic regulation, extracellular matrix remodeling, metabolic adaptation, and communication with other glial cells. Under physiological conditions, these processes support circuit refinement, synaptic stability, and cognition, which are modulated by circadian rhythms and the microbiota-gut-brain axis. In Alzheimer's disease, schizophrenia, and related disorders, microglial dysfunction can shift synaptic pruning from a controlled homeostatic process to pathological synapse loss. Excessive complement-mediated pruning, disrupted excitation-inhibition balance, neuroinflammation, and metabolic dysregulation may jointly impair synaptic integrity and circuit function. This review highlights microglial heterogeneity, state transitions, and targeted modulation as important directions for understanding synaptic remodeling and developing therapeutic strategies for neurological diseases.

Why This Matters for Body-Mind Practice

[Draft — editorial context needed]

Source

Original Publication
BMC medicine
Read Source →

Related

Stay Regulated

Regulate your nervous system from the inside out.

New research, honest product reviews, clinical trials, events, and funding news — delivered weekly, with zero sponsors or ads.